Search

everythinglearnresearchcommunity

for

Search:↓

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Fascial Manipulation treatment helped a woman with vulvodynia and other health issues.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Ayurvedic treatment helped a woman with PCOS resume regular periods and improve symptoms without side effects.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Exosomes show promise for improving wound healing, reducing aging signs, preventing hair loss, and lightening skin but require more research and better production methods.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.